| __timestamp | Geron Corporation | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 2395000 |
| Thursday, January 1, 2015 | 17831000 | 9057000 |
| Friday, January 1, 2016 | 18047000 | 40818000 |
| Sunday, January 1, 2017 | 11033000 | 79309000 |
| Monday, January 1, 2018 | 13432000 | 134428000 |
| Tuesday, January 1, 2019 | 52072000 | 175431000 |
| Wednesday, January 1, 2020 | 51488000 | 130944000 |
| Friday, January 1, 2021 | 85727000 | 121875000 |
| Saturday, January 1, 2022 | 95518000 | 115856000 |
| Sunday, January 1, 2023 | 125046000 | 130009000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, research and development (R&D) expenses serve as a critical indicator of a company's commitment to innovation. Over the past decade, Geron Corporation and Wave Life Sciences Ltd. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Wave Life Sciences Ltd. consistently outpaced Geron Corporation, with R&D expenses peaking at approximately 130% higher than Geron's in 2019. This trend underscores Wave's aggressive pursuit of cutting-edge therapies. Meanwhile, Geron Corporation's R&D spending surged by over 500% from 2014 to 2023, reflecting a renewed focus on advancing its clinical pipeline.
These financial commitments highlight the strategic priorities of each company, with Wave Life Sciences Ltd. leading in sheer investment, while Geron Corporation shows a remarkable growth trajectory in its R&D endeavors. Such insights offer a glimpse into the future of biotech innovation.
R&D Insights: How Sanofi and Geron Corporation Allocate Funds
Research and Development: Comparing Key Metrics for Incyte Corporation and Geron Corporation
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
R&D Insights: How Bio-Techne Corporation and Wave Life Sciences Ltd. Allocate Funds
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Geron Corporation
Veracyte, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Amicus Therapeutics, Inc. vs Geron Corporation
Analyzing R&D Budgets: HUTCHMED (China) Limited vs Geron Corporation
Research and Development Expenses Breakdown: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Geron Corporation or Wave Life Sciences Ltd.
Comparing Innovation Spending: Wave Life Sciences Ltd. and Amphastar Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Wave Life Sciences Ltd. and Celldex Therapeutics, Inc.